Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present

Updated on: April 10,2024

Immune cell responses in COVID-19 patients far from optimal

by Doherty Institute for Infection and ImmunityCredit: Thiago Lazarino from PixabayMelbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present

Updated on:April 10,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on: May 29,2024

New 3-D imaging analysis technique could lead to improved arthritis treatment

by University of CambridgeJoint space in hip, knee and ankle joints as analyzed by the JSM algorithm. Credit: Tom TurmezeiAn algorithm to monitor the joints of patients with arthritis, which coul

Updated on:May 29,2024

Study of infants and young children shows that offspring develop normally in mothers with rheumatic disease

by European League Against Rheumatism (EULAR)Credit: CC0 Public DomainAnkylosing spondylitis (AS) is a complex chronic inflammatory disease of the spine with involvement of the sacroiliac joints. Over

Updated on: June 26,2024

Study of infants and young children shows that offspring develop normally in mothers with rheumatic disease

by European League Against Rheumatism (EULAR)Credit: CC0 Public DomainAnkylosing spondylitis (AS) is a complex chronic inflammatory disease of the spine with involvement of the sacroiliac joints. Over

Updated on:June 26,2024

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

Updated on: April 20,2024

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

by Public Library of ScienceProject design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe

Updated on:April 20,2024

Sharing of skin microbiome between children with atopic dermatitis and healthy contacts might contribute to recurrence

by National University of SingaporeGraphical abstract. Credit:Journal of Allergy and Clinical Immunology(2022). DOI: 10.1016/j.jaci.2022.01.031Patients with moderate to severe atopic

Updated on: June 12,2024

Sharing of skin microbiome between children with atopic dermatitis and healthy contacts might contribute to recurrence

by National University of SingaporeGraphical abstract. Credit:Journal of Allergy and Clinical Immunology(2022). DOI: 10.1016/j.jaci.2022.01.031Patients with moderate to severe atopic

Updated on:June 12,2024

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit

Updated on: May 07,2024

A year of COVID-19 lockdown is putting kids at risk of allergies, asthma and autoimmune diseases

by Byram W. Bridle,The ConversationCredit: Unsplash/CC0 Public Domain"Eat dirt!" is a phrase I remember well. It was in thetitle of an articlepublished by Harvard Universit

Updated on:May 07,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on: June 17,2024

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

Updated on:June 17,2024

Study: Why people with knee osteoarthritis experience different kinds of pain

by Boston University School of MedicineCredit: CC0 Public DomainOsteoarthritis is the most common form of arthritis worldwide, affecting more than 300 million people. It causes substantial pain,

Updated on: April 17,2024

Study: Why people with knee osteoarthritis experience different kinds of pain

by Boston University School of MedicineCredit: CC0 Public DomainOsteoarthritis is the most common form of arthritis worldwide, affecting more than 300 million people. It causes substantial pain,

Updated on:April 17,2024

Study finds holding methotrexate for one week after flu vaccine may be as effective as a two-week hold

by American College of RheumatologyStudy design and vaccine response at 4 and 16 weeks. (A) Study design. (B) The percentage of patients achieving a satisfactory vaccine response, defined as ≥4-f

Updated on: July 02,2024

Study finds holding methotrexate for one week after flu vaccine may be as effective as a two-week hold

by American College of RheumatologyStudy design and vaccine response at 4 and 16 weeks. (A) Study design. (B) The percentage of patients achieving a satisfactory vaccine response, defined as ≥4-f

Updated on:July 02,2024

COVID-19: The older you are, the more antibodies you have

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWith the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerat

Updated on: April 10,2024

COVID-19: The older you are, the more antibodies you have

by University of MontrealA colorized scanning electron micrograph of the SARS-CoV-2 virus. Credit: NIAIDWith the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerat

Updated on:April 10,2024

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul

Updated on: April 09,2024

Cell-compressing technique a new path in immunotherapy

by Zach Winn,Massachusetts Institute of TechnologyTo engineer cell functions, SQZ Biotech uses tiny channels on a microfluidic chip to squeeze cells so they can be penetrated by specific molecul

Updated on:April 09,2024

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch

Updated on: April 13,2024

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch

Updated on:April 13,2024